Page last updated: 2024-10-26

erythrosine and Chronic Kidney Disease-Mineral and Bone Disorder

erythrosine has been researched along with Chronic Kidney Disease-Mineral and Bone Disorder in 1 studies

Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.

Chronic Kidney Disease-Mineral and Bone Disorder: Decalcification of bone or abnormal bone development due to chronic KIDNEY DISEASES, in which 1,25-DIHYDROXYVITAMIN D3 synthesis by the kidneys is impaired, leading to reduced negative feedback on PARATHYROID HORMONE. The resulting SECONDARY HYPERPARATHYROIDISM eventually leads to bone disorders.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yukihiro, S1
Okada, S1
Takeuchi, K1
Inoue, H1

Other Studies

1 other study available for erythrosine and Chronic Kidney Disease-Mineral and Bone Disorder

ArticleYear
Experimental osteodystrophy of chronic renal failure induced by aluminum- and ferric-nitrilotriacetate in Wistar rats.
    Pathology international, 1995, Volume: 45, Issue:1

    Topics: Animals; Chronic Kidney Disease-Mineral and Bone Disorder; Ferric Compounds; Fluoresceins; Kidney; M

1995